Butyrate is a short chain fatty acid derived from the microbial fermentation of dietary fibers in the colon. In the last decade, multiple beneficial effects of butyrate at intestinal and extraintestinal level have been demonstrated. The mechanisms of action of butyrate are different and many of these involve an epigenetic regulation of gene expression through the inhibition of histone deacetylase. There is a growing interest in butyrate because its impact on epigenetic mechanisms will lead to more specific and efficacious therapeutic strategies for the prevention and treatment of different diseases ranging from genetic/metabolic conditions to neurological degenerative disorders. This review is focused on recent data regarding the epigenetic effects of butyrate with potential clinical implications in human medicine.

The epigenetic effects of butyrate : potential therapeutic implications for clinical practice / R. Berni Canani, M. Di Costanzo, L. Leone. - In: CLINICAL EPIGENETICS. - ISSN 1868-7083. - 4:1(2012 Feb), pp. 4.1-4.7. [10.1186/1868-7083-4-4]

The epigenetic effects of butyrate : potential therapeutic implications for clinical practice

L. Leone
Ultimo
2012-02

Abstract

Butyrate is a short chain fatty acid derived from the microbial fermentation of dietary fibers in the colon. In the last decade, multiple beneficial effects of butyrate at intestinal and extraintestinal level have been demonstrated. The mechanisms of action of butyrate are different and many of these involve an epigenetic regulation of gene expression through the inhibition of histone deacetylase. There is a growing interest in butyrate because its impact on epigenetic mechanisms will lead to more specific and efficacious therapeutic strategies for the prevention and treatment of different diseases ranging from genetic/metabolic conditions to neurological degenerative disorders. This review is focused on recent data regarding the epigenetic effects of butyrate with potential clinical implications in human medicine.
epigenome; histone deacetylase inhibitor; short chain fatty acids
Settore MED/38 - Pediatria Generale e Specialistica
Article (author)
File in questo prodotto:
File Dimensione Formato  
art_10.1186_1868-7083-4-4.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 465.51 kB
Formato Adobe PDF
465.51 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/467284
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 249
  • ???jsp.display-item.citation.isi??? 233
social impact